Does the media prefer ICUI or QDEL?

In the previous week, ICU Medical had 6 more articles in the media than QuidelOrtho. MarketBeat recorded 13 mentions for ICU Medical and 7 mentions for QuidelOrtho. QuidelOrtho's average media sentiment score of 1.04 beat ICU Medical's score of 0.73 indicating that QuidelOrtho is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ICU Medical 9 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive QuidelOrtho 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to HAE or QDEL?

In the previous week, Haemonetics had 4 more articles in the media than QuidelOrtho. MarketBeat recorded 11 mentions for Haemonetics and 7 mentions for QuidelOrtho. QuidelOrtho's average media sentiment score of 1.04 beat Haemonetics' score of 0.69 indicating that QuidelOrtho is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Haemonetics 6 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive QuidelOrtho 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to QDEL or XRAY?

In the previous week, DENTSPLY SIRONA had 2 more articles in the media than QuidelOrtho. MarketBeat recorded 9 mentions for DENTSPLY SIRONA and 7 mentions for QuidelOrtho. QuidelOrtho's average media sentiment score of 1.04 beat DENTSPLY SIRONA's score of 0.83 indicating that QuidelOrtho is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment QuidelOrtho 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive DENTSPLY SIRONA 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is NEOG or QDEL more profitable?

Neogen has a net margin of -0.91% compared to QuidelOrtho's net margin of -45.57%. QuidelOrtho's return on equity of 4.25% beat Neogen's return on equity. Company Net Margins Return on Equity Return on Assets Neogen -0.91% 2.78% 1.74% QuidelOrtho -45.57% 4.25% 1.56%

Does the media prefer NEOG or QDEL?

In the previous week, Neogen had 17 more articles in the media than QuidelOrtho. MarketBeat recorded 24 mentions for Neogen and 7 mentions for QuidelOrtho. QuidelOrtho's average media sentiment score of 1.04 beat Neogen's score of 0.58 indicating that QuidelOrtho is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neogen 6 Very Positive mention(s) 0 Positive mention(s) 13 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive QuidelOrtho 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to STAA or QDEL?

In the previous week, STAAR Surgical had 2 more articles in the media than QuidelOrtho. MarketBeat recorded 9 mentions for STAAR Surgical and 7 mentions for QuidelOrtho. QuidelOrtho's average media sentiment score of 1.04 beat STAAR Surgical's score of 0.51 indicating that QuidelOrtho is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 1 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive QuidelOrtho 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

QuidelOrtho (QDEL) Competitors

$17.34 -0.38 (-2.12%)

As of 02:57 PM Eastern

Compare

QDEL vs. ICUI, HAE, XRAY, NEOG, and STAA

Should you buy QuidelOrtho stock or one of its competitors? MarketBeat compares QuidelOrtho with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with QuidelOrtho include ICU Medical (ICUI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), Neogen (NEOG), and STAAR Surgical (STAA).

How does QuidelOrtho compare to ICU Medical?

ICU Medical (NASDAQ:ICUI) and QuidelOrtho (NASDAQ:QDEL) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, media sentiment, institutional ownership, earnings, dividends and profitability.

ICU Medical has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market. Comparatively, QuidelOrtho has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market.

ICU Medical has higher earnings, but lower revenue than QuidelOrtho. QuidelOrtho is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ICU Medical	$2.16B	1.99	$730K	$1.85	92.68
QuidelOrtho	$2.73B	0.43	-$1.13B	-$17.82	N/A

In the previous week, ICU Medical had 6 more articles in the media than QuidelOrtho. MarketBeat recorded 13 mentions for ICU Medical and 7 mentions for QuidelOrtho. QuidelOrtho's average media sentiment score of 1.04 beat ICU Medical's score of 0.73 indicating that QuidelOrtho is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ICU Medical	9 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
QuidelOrtho	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

ICU Medical has a net margin of 2.15% compared to QuidelOrtho's net margin of -45.57%. ICU Medical's return on equity of 7.50% beat QuidelOrtho's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ICU Medical	2.15%	7.50%	3.91%
QuidelOrtho	-45.57%	4.25%	1.56%

96.1% of ICU Medical shares are held by institutional investors. Comparatively, 99.0% of QuidelOrtho shares are held by institutional investors. 2.1% of ICU Medical shares are held by company insiders. Comparatively, 1.1% of QuidelOrtho shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

ICU Medical currently has a consensus price target of $172.00, indicating a potential upside of 0.32%. QuidelOrtho has a consensus price target of $13.63, indicating a potential downside of 21.42%. Given ICU Medical's stronger consensus rating and higher possible upside, equities analysts plainly believe ICU Medical is more favorable than QuidelOrtho.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ICU Medical	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.89
QuidelOrtho	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Summary

ICU Medical beats QuidelOrtho on 14 of the 17 factors compared between the two stocks.

How does QuidelOrtho compare to Haemonetics?

Haemonetics (NYSE:HAE) and QuidelOrtho (NASDAQ:QDEL) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.

Haemonetics has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market. Comparatively, QuidelOrtho has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market.

In the previous week, Haemonetics had 4 more articles in the media than QuidelOrtho. MarketBeat recorded 11 mentions for Haemonetics and 7 mentions for QuidelOrtho. QuidelOrtho's average media sentiment score of 1.04 beat Haemonetics' score of 0.69 indicating that QuidelOrtho is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haemonetics	6 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
QuidelOrtho	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Haemonetics currently has a consensus target price of $78.89, suggesting a potential downside of 8.76%. QuidelOrtho has a consensus target price of $13.63, suggesting a potential downside of 21.42%. Given Haemonetics' stronger consensus rating and higher possible upside, equities analysts plainly believe Haemonetics is more favorable than QuidelOrtho.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haemonetics	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.82
QuidelOrtho	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Haemonetics has higher earnings, but lower revenue than QuidelOrtho. QuidelOrtho is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haemonetics	$1.33B	2.95	$97.31M	$2.02	42.81
QuidelOrtho	$2.73B	0.43	-$1.13B	-$17.82	N/A

Haemonetics has a net margin of 7.29% compared to QuidelOrtho's net margin of -45.57%. Haemonetics' return on equity of 27.30% beat QuidelOrtho's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haemonetics	7.29%	27.30%	9.59%
QuidelOrtho	-45.57%	4.25%	1.56%

99.7% of Haemonetics shares are held by institutional investors. Comparatively, 99.0% of QuidelOrtho shares are held by institutional investors. 2.1% of Haemonetics shares are held by insiders. Comparatively, 1.1% of QuidelOrtho shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Haemonetics beats QuidelOrtho on 14 of the 17 factors compared between the two stocks.

How does QuidelOrtho compare to DENTSPLY SIRONA?

QuidelOrtho (NASDAQ:QDEL) and DENTSPLY SIRONA (NASDAQ:XRAY) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

99.0% of QuidelOrtho shares are held by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are held by institutional investors. 1.1% of QuidelOrtho shares are held by company insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

QuidelOrtho presently has a consensus price target of $13.63, suggesting a potential downside of 21.42%. DENTSPLY SIRONA has a consensus price target of $13.46, suggesting a potential downside of 4.99%. Given DENTSPLY SIRONA's stronger consensus rating and higher possible upside, analysts plainly believe DENTSPLY SIRONA is more favorable than QuidelOrtho.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QuidelOrtho	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
DENTSPLY SIRONA	3 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

QuidelOrtho has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.85, meaning that its share price is 15% less volatile than the broader market.

In the previous week, DENTSPLY SIRONA had 2 more articles in the media than QuidelOrtho. MarketBeat recorded 9 mentions for DENTSPLY SIRONA and 7 mentions for QuidelOrtho. QuidelOrtho's average media sentiment score of 1.04 beat DENTSPLY SIRONA's score of 0.83 indicating that QuidelOrtho is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
QuidelOrtho	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
DENTSPLY SIRONA	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

DENTSPLY SIRONA has higher revenue and earnings than QuidelOrtho. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QuidelOrtho	$2.73B	0.43	-$1.13B	-$17.82	N/A
DENTSPLY SIRONA	$3.68B	0.77	-$598M	-$3.15	N/A

DENTSPLY SIRONA has a net margin of -17.06% compared to QuidelOrtho's net margin of -45.57%. DENTSPLY SIRONA's return on equity of 18.83% beat QuidelOrtho's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
QuidelOrtho	-45.57%	4.25%	1.56%
DENTSPLY SIRONA	-17.06%	18.83%	5.13%

Summary

DENTSPLY SIRONA beats QuidelOrtho on 12 of the 16 factors compared between the two stocks.

How does QuidelOrtho compare to Neogen?

Neogen (NASDAQ:NEOG) and QuidelOrtho (NASDAQ:QDEL) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, risk, profitability, institutional ownership and earnings.

Neogen currently has a consensus price target of $11.67, indicating a potential downside of 2.43%. QuidelOrtho has a consensus price target of $13.63, indicating a potential downside of 21.42%. Given Neogen's stronger consensus rating and higher possible upside, research analysts plainly believe Neogen is more favorable than QuidelOrtho.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neogen	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
QuidelOrtho	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Neogen has higher earnings, but lower revenue than QuidelOrtho. Neogen is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neogen	$870.40M	3.00	-$7.90M	-$0.03	N/A
QuidelOrtho	$2.73B	0.43	-$1.13B	-$17.82	N/A

In the previous week, Neogen had 17 more articles in the media than QuidelOrtho. MarketBeat recorded 24 mentions for Neogen and 7 mentions for QuidelOrtho. QuidelOrtho's average media sentiment score of 1.04 beat Neogen's score of 0.58 indicating that QuidelOrtho is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neogen	6 Very Positive mention(s)	0 Positive mention(s)	13 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
QuidelOrtho	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

96.7% of Neogen shares are owned by institutional investors. Comparatively, 99.0% of QuidelOrtho shares are owned by institutional investors. 0.6% of Neogen shares are owned by insiders. Comparatively, 1.1% of QuidelOrtho shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Neogen has a net margin of -0.91% compared to QuidelOrtho's net margin of -45.57%. QuidelOrtho's return on equity of 4.25% beat Neogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neogen	-0.91%	2.78%	1.74%
QuidelOrtho	-45.57%	4.25%	1.56%

Neogen has a beta of 1.76, meaning that its share price is 76% more volatile than the broader market. Comparatively, QuidelOrtho has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market.

Summary

Neogen beats QuidelOrtho on 10 of the 16 factors compared between the two stocks.

How does QuidelOrtho compare to STAAR Surgical?

STAAR Surgical (NASDAQ:STAA) and QuidelOrtho (NASDAQ:QDEL) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment and institutional ownership.

96.7% of STAAR Surgical shares are held by institutional investors. Comparatively, 99.0% of QuidelOrtho shares are held by institutional investors. 39.9% of STAAR Surgical shares are held by insiders. Comparatively, 1.1% of QuidelOrtho shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, STAAR Surgical had 2 more articles in the media than QuidelOrtho. MarketBeat recorded 9 mentions for STAAR Surgical and 7 mentions for QuidelOrtho. QuidelOrtho's average media sentiment score of 1.04 beat STAAR Surgical's score of 0.51 indicating that QuidelOrtho is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	1 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
QuidelOrtho	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

STAAR Surgical has higher earnings, but lower revenue than QuidelOrtho. STAAR Surgical is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	5.02	-$80.45M	-$0.43	N/A
QuidelOrtho	$2.73B	0.43	-$1.13B	-$17.82	N/A

STAAR Surgical currently has a consensus target price of $26.94, indicating a potential upside of 11.53%. QuidelOrtho has a consensus target price of $13.63, indicating a potential downside of 21.42%. Given STAAR Surgical's stronger consensus rating and higher possible upside, research analysts plainly believe STAAR Surgical is more favorable than QuidelOrtho.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	3 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
QuidelOrtho	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

STAAR Surgical has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market. Comparatively, QuidelOrtho has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market.

STAAR Surgical has a net margin of -7.24% compared to QuidelOrtho's net margin of -45.57%. QuidelOrtho's return on equity of 4.25% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	-7.24%	3.31%	2.55%
QuidelOrtho	-45.57%	4.25%	1.56%

Summary

STAAR Surgical beats QuidelOrtho on 11 of the 16 factors compared between the two stocks.

Get QuidelOrtho News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QDEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QDEL vs. The Competition

Export

Metric	QuidelOrtho	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.18B	$5.70B	$6.80B	$13.01B
Dividend Yield	N/A	1.78%	2.60%	10.03%
P/E Ratio	-0.97	23.54	279.98	25.51
Price / Sales	0.43	59.23	649.35	116.02
Price / Cash	0.89	32.53	28.64	34.82
Price / Book	0.61	6.50	11.15	6.35
Net Income	-$1.13B	$151.72M	$3.48B	$347.60M
7 Day Performance	4.01%	6.11%	2.51%	3.14%
1 Month Performance	-4.99%	0.89%	-2.78%	-2.08%
1 Year Performance	-28.08%	9.82%	64.32%	21.27%

QuidelOrtho Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QDEL QuidelOrtho	2.0157 of 5 stars	$17.34 -2.1%	$13.63 -21.4%	-22.4%	$1.18B	$2.73B	N/A	6,500	News Coverage Positive News Upcoming Earnings
ICUI ICU Medical	2.3868 of 5 stars	$161.46 +2.6%	$172.00 +6.5%	+35.7%	$3.93B	$2.23B	87.28	13,000	News Coverage Upcoming Earnings
HAE Haemonetics	2.3001 of 5 stars	$80.07 +1.6%	$78.89 -1.5%	+16.2%	$3.58B	$1.33B	39.64	3,009	News Coverage Upcoming Earnings
XRAY DENTSPLY SIRONA	3.3708 of 5 stars	$13.02 +0.7%	$13.42 +3.0%	-1.2%	$2.59B	$3.68B	N/A	14,000	Positive News Upcoming Earnings
NEOG Neogen	1.4095 of 5 stars	$9.34 -0.6%	$10.67 +14.2%	+155.4%	$2.05B	$870.56M	N/A	2,110	Earnings Report Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QDEL) was last updated on 8/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

QuidelOrtho (QDEL) Competitors

QDEL vs. ICUI, HAE, XRAY, NEOG, and STAA

How does QuidelOrtho compare to ICU Medical?

Summary

How does QuidelOrtho compare to Haemonetics?

Summary

How does QuidelOrtho compare to DENTSPLY SIRONA?

Summary

How does QuidelOrtho compare to Neogen?

Summary

How does QuidelOrtho compare to STAAR Surgical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QDEL vs. The Competition

QuidelOrtho Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

QuidelOrtho (QDEL) Competitors

QDEL vs. ICUI, HAE, XRAY, NEOG, and STAA

How does QuidelOrtho compare to ICU Medical?

Which has more risk and volatility, ICUI or QDEL?

Which has higher valuation & earnings, ICUI or QDEL?

Does the media prefer ICUI or QDEL?

Is ICUI or QDEL more profitable?

Do insiders and institutionals believe in ICUI or QDEL?

Do analysts recommend ICUI or QDEL?

Summary

How does QuidelOrtho compare to Haemonetics?

Which has more risk & volatility, HAE or QDEL?

Does the media refer more to HAE or QDEL?

Do analysts recommend HAE or QDEL?

Which has better valuation & earnings, HAE or QDEL?

Is HAE or QDEL more profitable?

Do insiders & institutionals have more ownership in HAE or QDEL?

Summary

How does QuidelOrtho compare to DENTSPLY SIRONA?

Do insiders & institutionals hold more shares of QDEL or XRAY?

Do analysts recommend QDEL or XRAY?

Which has more risk & volatility, QDEL or XRAY?

Does the media refer more to QDEL or XRAY?

Which has higher valuation & earnings, QDEL or XRAY?

Is QDEL or XRAY more profitable?

Summary

How does QuidelOrtho compare to Neogen?

Do analysts rate NEOG or QDEL?

Which has better earnings and valuation, NEOG or QDEL?

Does the media prefer NEOG or QDEL?

Do institutionals & insiders hold more shares of NEOG or QDEL?

Is NEOG or QDEL more profitable?

Which has more volatility & risk, NEOG or QDEL?

Summary

How does QuidelOrtho compare to STAAR Surgical?

Do insiders & institutionals hold more shares of STAA or QDEL?

Does the media refer more to STAA or QDEL?

Which has better valuation & earnings, STAA or QDEL?

Do analysts recommend STAA or QDEL?

Which has more risk & volatility, STAA or QDEL?

Is STAA or QDEL more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QDEL vs. The Competition

QuidelOrtho Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools